Immunomarkers, such as chromogranian and synaptophysin, Melan A and HMB45 or desmin and smooth muscle actin, are applied to differentiate neuroendocrine, melanoma and smooth muscle tumors, respectively. This evidence concerns the gene MLANA and smooth muscle tumor.